Immuneering Corporation (IMRX)

Last Closing Price: 6.73 (2025-12-26)

Debt to Equity Ratio (Quarterly)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

Immuneering Corporation (IMRX) Debt to Equity Ratio data is not available.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
--
$-14.96M
--
--
$15.38M
$-15.38M
$0.42M
$-14.96M
$-14.96M
$-14.96M
$-14.96M
$-14.96M
$-14.96M
$-15.38M
$-15.21M
39.67M
39.67M
$-0.38
$-0.38
Balance Sheet Financials
$229.10M
$0.89M
$11.95M
$241.06M
$9.55M
--
$3.53M
$13.08M
$227.98M
$220.96M
$227.98M
63.48M
Cash Flow Statement Financials
$-35.50M
$-0.02M
$226.94M
$36.14M
$227.56M
$191.42M
$4.67M
--
--
Fundamental Metrics & Ratios
24.00
--
--
--
Debt to Equity Ratio
--
--
--
--
--
--
--
$-35.52M
--
--
--
--
--
--
--
-6.56%
-6.77%
-6.21%
-6.56%
$3.59
$-0.90
$-0.90